ORamaVR raises 2.4M EUR in a post-seed funding round
Share this article
The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the training of medical professionals on a large scale
The lack of access to affordable surgical care today has created a major health crisis currently affecting almost 5 billion people globally. The World Health Organization (WHO) is projecting that by 2030 there will be a staggering deficit of 18 million medical professionals. The lack of innovation in medical professional training over the last 150 years is an important driver of this crisis.
ORamaVR, a Swiss deep-tech startup with R&D in Greece has been tackling this crisis since it was founded in 2020. Its clinical studies have proven that medical VR training improves patient outcomes. However, the creation of medical VR training modules is traditionally very costly and time-consuming. ORamaVR has solved this problem. Using its proprietary authoring tools, ORamaVR’s and its clients can create high-quality medical training modules faster and more resource efficiently, but at a lower cost.
After getting a CHF 12 million Innosuisse grant, ORamaVR recently raised 2.4M EUR in post-seed funding through non-dilutive and convertible note financing, led by the European Union NextGenerationEU and HorizonEurope programmes, as well as the Geneva Foundation for Technology Innovation (Fongit) and FORTH-ICS .
The funds will support ORamaVR in tackling the crisis by accelerating the world’s transition to medical virtual reality training.
ORamaVR announces the appointment of Craig Patterson as a new board member. Craig Patterson is currently the CFO of Celero Systems and has over 25 years of experience in the medical device sector.
The company is supported by Fongit, where interested parties can contact for partnerships and collaborations.
Source: Press Release